Sava Technologies key facts
as of Oct 2026- Developer of biosensing technology designed to provide real-time feedback about the body's molecular signature.
- Sava Technologies is valued at approximately $55.9M as of Oct 2026 (last reported valuation).
- It has raised $46.4M; the latest was Later Stage VC ($25.7M) in Jul 2025.
- Notable investors include Innovate UK, MassChallenge, SOSV, Joyance Partners, Balderton Capital — 24 tracked in total.
- Status: Privately Held (backing).
Sava Technologies's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·The complete investor list: 24 names
- ·Watch Sava Technologies: the Monday email on marks, rounds and moves
Sava Technologies funding rounds
No funding rounds for Sava Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Sava Technologies
24+Membership and data by Private Market View
Sava Technologies valuation
Sava Technologies's last reported valuation was $55.9 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Sava Technologies investors
24 investors are on record for Sava Technologies, including Innovate UK, MassChallenge, SOSV and Joyance Partners. By type, the record holds 4 venture capital firms and 1 private equity firm.
About Sava Technologies
Developer of biosensing technology designed to provide real-time feedback about the body's molecular signature. The company's technology offers continuous monitoring of glucose and lactate to train smarter, predict exhaustion, and provide optimal dietary plans, enabling athletes to get bodily information in real-time.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2016
- Employees
- 60
- Website
- sava.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.